🧬 BDNF Extraction Viewer

Извлечено: 997 / 997 (100.0%) Средняя confidence: 0.13
← Назад к списку

Dietary Advanced Glycation End Products Induced Anxiety- and Depression-like Behaviors in Female C57BL/6 Mice and the Ameliorative Effects of Quercetin.

PMID: 41962780 · DOI: 10.1016/j.jnutbio.2026.110363 · The Journal of nutritional biochemistry, 2026 · Tongtong Ma, Zhilong He, Guoqi Yang, Jijiao Cai, Li-Qiang Qin, Yu Xia, Zhongxiao Wan
📄 Abstract

Quercetin is a flavonoid bioactive compound with potential anti-depression effect. Dietary advanced glycation end products (AGEs) might be critically associated with depression. We aimed to explore whether quercetin ameliorates dietary AGEs-induced anxiety and depression-like behaviors in female mice, with a focus on hypothalamic-pituitary-adrenal axis (HPA) regulation and gut microbiota composition. Mice were divided into three groups: control, dietary AGEs, and AGEs plus quercetin. Dietary AGEs induced anxiety and depression-like behavioral effects, reduced BDNF, P-CREB, PSD95, doublecortin, and synaptophysin protein expression. Dietary AGEs induced HPA axis overactivation has been confirmed by decreased hippocampal GR, P-GR S211, and arginase-1, and elevated FKBP51, NLRP3, caspase-1, and p65 protein expression. Dietary AGEs resulted in gut microbiota disorder and correlation analysis revealed significant associations between Proteobacteria, the [Eubacterium] coprostanoligenes group, Klebsiella and Lachnospiraceae_NK4A136_group with behavioral parameters. Quercetin intervention improved dietary AGEs associated anxiety and depression-like behavioral effects via restoring HPA axis and gut microbiota.

Confidence: 0.26 · 13 полей извлечено
Идентификация (6 полей)
Target
Quercetin
0.95
Alt. target
—
0.00
Protein family
Flavonoid
0.90
Functional class
Bioactive compound
0.80
Subcellular loc.
—
0.00
Isoforms (metab/obesity)
—
0.00
Механизм действия (21 полей)
Mechanism
—
0.00
Mutations (obesity/lean)
—
0.00
Activity (obesity)
—
0.00
Activity temporal
—
0.00
Energy balance
—
0.00
Appetite
—
0.00
Fat metabolism
—
0.00
Lipolysis
—
0.00
Thermogenesis
—
0.00
Muscle metabolism
—
0.00
Inflammation
—
0.00
Glucose metabolism
—
0.00
AA metabolism
—
0.00
Hormonal pathways
—
0.00
Cell death
—
0.00
Adipocyte fibrosis
—
0.00
Upstream (biochem)
—
0.00
Upstream (physiol)
—
0.00
Downstream (biochem)
—
0.00
Downstream (physiol)
—
0.00
PTMs
—
0.00
Экспрессия (8 полей)
Tissue expression
hippocampal GR, P-GR S211, arginase-1, FKBP51, NLRP3, caspase-1, p65, BDNF, P-CREB, PSD95, doublecortin, synaptophysin
0.90
In vitro
—
0.00
In vivo
female C57BL/6 mice divided into three groups: control, dietary AGEs, and AGEs plus quercetin
0.95
In silico
—
0.00
Genetic association
—
0.00
Ex vivo
—
0.00
Animal model
female C57BL/6 mice
0.95
Diet/model
dietary advanced glycation end products (AGEs)
0.95
Клиника (11 полей)
Drug
Quercetin
0.95
Indication
Anxiety and depression-like behaviors induced by dietary advanced glycation end products
0.90
Patient subgroups
Female C57BL/6 mice
0.85
Safety concerns
—
0.00
Off-target
—
0.00
Trial stage
Preclinical (animal study)
0.90
Pharma competitors
—
0.00
AE severity
—
0.00
MOA weight loss
—
0.00
Endpoints
Improved anxiety and depression-like behavioral effects, restored HPA axis, and gut microbiota composition
0.90
Approved
False
0.95